Patton Boggs Advises Intezyne Technologies in Acquisition of Niiki Pharma

An M&A team from Patton Boggs LLP headed by Geoff Davis, a partner in the firm’s Washington DC office and Mark Goldschmidt, a partner in the firm’s Denver office recently represented Intezyne Technologies, a leader in the use of nanotechnology in the development of cancer treatment, in its strategic acquisition of target Niiki Pharma, significantly expanding Intezyne’s portfolio of cancer drugs and market valuation.

More >>

Tags:  Squire Patton Boggs

Davis Polk Advises Sumitomo Mitsui Banking Corporation on $2 Billion Concurrent Guaranteed Senior Bond Offerings

Davis Polk advised Sumitomo Mitsui Banking Corporation in connection with its $2 billion senior debt offering in reliance on the Section 3(a)(2) exemption of the Securities Act. The offering consisted of $500 million of 1.45% senior bonds due 2016, $500 million of 2.5% senior bonds due 2018, $700 million of 3.95% senior bonds due 2023 and $300 million of 3.95% senior floating-rate bonds due 2016, each guaranteed by Sumitomo Mitsui Banking Corporation’s New York branch. The joint lead managers for the offering were Goldman, Sachs & Co., Citigroup Global Markets Inc., Barclays Bank PLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and SMBC Nikko Securities Inc.

More >>

Tags:  Davis Polk & Wardwell LLP | Tokyo